{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:04:43Z","timestamp":1788383083303,"version":"build-2803163510"},"reference-count":26,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["123"],"award-info":[{"award-number":["123"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1136\/thorax-2023-221329","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T18:20:39Z","timestamp":1708366839000},"page":"291-292","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease"],"prefix":"10.1136","volume":"79","author":[{"given":"Nayia","family":"Petousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4288-5973","authenticated-orcid":false,"given":"Ian D","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7499-7454","authenticated-orcid":false,"given":"Brian Daniel","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"2025042101250961000_79.4.291.1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"The Lancet"},{"key":"2025042101250961000_79.4.291.2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.201912-2384PP","article-title":"Blood eosinophil counts in clinical trials for chronic obstructive pulmonary disease","volume":"202","author":"Singh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025042101250961000_79.4.291.3","doi-asserted-by":"publisher","DOI":"10.1038\/nri3786"},{"key":"2025042101250961000_79.4.291.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2032506"},{"key":"2025042101250961000_79.4.291.5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cea.12881","article-title":"The current and future role of biomarkers in type 2 cytokine-mediated asthma management","volume":"47","author":"Pavord","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2025042101250961000_79.4.291.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217325"},{"key":"2025042101250961000_79.4.291.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.10.015"},{"key":"2025042101250961000_79.4.291.8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaip.2023.01.008","article-title":"Toward a predict and prevent approach in obstructive airway diseases","volume":"11","author":"Couillard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025042101250961000_79.4.291.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201903-0599LE"},{"key":"2025042101250961000_79.4.291.10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1164\/rccm.202006-2618OC","article-title":"Reduced all-cause mortality in the ETHOS trial of Budesonide\/glycopyrrolate\/Formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study","volume":"203","author":"Martinez","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025042101250961000_79.4.291.11","first-page":"350","article-title":"Type-2 inflammation and lung function decline in chronic airway disease in the general population","volume":"79","author":"\u00c7olak","year":"2024","journal-title":"Thorax"},{"key":"2025042101250961000_79.4.291.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00838-2020"},{"key":"2025042101250961000_79.4.291.13","doi-asserted-by":"crossref","unstructured":"Hancox RJ , Pavord ID , Sears MR . Associations between blood eosinophils and decline in lung function among adults with and without asthma. Eur Respir J 2018;51. doi:10.1183\/13993003.02536-2017","DOI":"10.1183\/13993003.02536-2017"},{"key":"2025042101250961000_79.4.291.14","doi-asserted-by":"crossref","unstructured":"Coumou H , Westerhof GA , de Nijs SB , et al . Predictors of accelerated decline in lung function in adult-onset asthma. Eur Respir J 2018;51. doi:10.1183\/13993003.01785-2017","DOI":"10.1183\/13993003.01785-2017"},{"key":"2025042101250961000_79.4.291.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303951"},{"key":"2025042101250961000_79.4.291.16","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00204-2019"},{"key":"2025042101250961000_79.4.291.17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaip.2022.11.043","article-title":"Baseline feno independently predicts the dupilumab response in patients with moderate-to-severe asthma","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"#cr-split#-2025042101250961000_79.4.291.18.1","doi-asserted-by":"crossref","unstructured":"Pavord ID , Brusselle G , Jackson DJ , et al . FeNO as a potential prognostic and predictive marker of lung function decline in patients with uncontrolled, moderate-to-severe ASTHMA: LIBERTY ASTHMA QUEST. American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A3418"},{"key":"#cr-split#-2025042101250961000_79.4.291.18.2","doi-asserted-by":"crossref","unstructured":"May 2022 doi:10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A3418","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A3418"},{"key":"2025042101250961000_79.4.291.19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/resp.14213","article-title":"Fluticasone furoate: captain of fluticasones in type 2 inflammatory asthma","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"key":"2025042101250961000_79.4.291.20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"key":"2025042101250961000_79.4.291.21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaip.2020.07.055","article-title":"Blood eosinophil count as a predictor of lung function decline in healthy individuals","volume":"9","author":"Lee","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025042101250961000_79.4.291.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03823-2020"},{"key":"2025042101250961000_79.4.291.23","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2147\/COPD.S172240","article-title":"Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025042101250961000_79.4.291.24","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212441"},{"key":"2025042101250961000_79.4.291.25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00679-2022"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-221329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T10:59:32Z","timestamp":1745233172000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-221329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/thorax-2023-221329"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-221329","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]}}}